Dorsey Wright & Associates Pro Qr Therapeutics N.V. Transaction History

Dorsey Wright & Associates

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 27, 2022	SELL	$0.9 - $8.39 $6,174 - $57,555	-6,860 Closed	0 $0
Q4 2021 Jan 27, 2022	BUY	$6.58 - $8.44 $45,138 - $57,898	6,860 New	6,860 $55,000
Q1 2019 Apr 04, 2019	SELL	$12.5 - $18.48 $12,000 - $17,740	-960 Closed	0 $0
Q4 2018 Jan 07, 2019	BUY	$15.25 - $22.4 $14,640 - $21,504	960 New	960 $15,000

17.4M

52.5K

11.8K

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $121M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.